|
Dr. Schnipper joined Novacea from CellGate Inc., a privately-held biotechnology company, with more than 18 years of management experience in the clinical development of medicines for the pharmaceutical and biotechnology industries. Dr. Schnipper has been responsible for numerous clinical trial programs that served to support successful New Drug Application strategies and competitive market positions for new therapeutic products. Prior to CellGate, Dr. Schnipper was vice president of Clinical Development at ALZA Corporation. Before joining ALZA, Dr. Schnipper served as senior vice president and medical director at SEQUUS Pharmaceuticals, where he was responsible for clinical and regulatory functions and a member of the Executive Committee. Between 1983 and 1996, he held various positions at Hoffmann-La Roche, culminating in his appointment as vice president of Clinical Operations, Virology. Dr. Schnipper earned his B.A. degree from Hobart College in Geneva, New York and his M.D. from the Georgetown University School of Medicine in Washington, DC. He trained in medicine at the Long Island Jewish-Hillside Medical Center and completed fellowships in hematology at New York University and in medical oncology at Memorial Sloan-Kettering Cancer Center in New York. He is a member of the American Society of Clinical Oncology and the American Academy of Pharmaceutical Physicians, among other professional societies. | 